M&T Bank Corp Bluebird Bio, Inc. Transaction History

M&T Bank Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$59.47 - $93.1 $100,980 - $158,083	-1,698 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$75.84 - $105.21 $34,583 - $47,975	-456 Reduced 21.17%	1,698 $215,000
Q1 2019 May 15, 2019	SELL	$64.44 - $104.11 $5,090 - $8,224	-79 Reduced 3.54%	2,154 $338,000
Q4 2018 Feb 01, 2019	BUY	$59.1 - $93.26 $131,970 - $208,249	2,233 New	2,233 $221,000

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $27M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

Stay updated on M&T Bank Corp with notifications on news.